WHAT IS NEW?
1. CD15+LOX-1+ PMN-MDSC frequency is increased in PB cells of NSCLC patients, and is a potential biomarker for NSCLC diagnosis.
2. The proportion of CD15+LOX-1+PMN-MDSCs is associated with NSCLC prognosis and recurrence after surgery.